Search Results - "Dutta, P.R."

Omission of Elective Retropharyngeal Nodal Irradiation Superior to Vertebral Level C1 is Not Associated With Retropharyngeal Nodal Failure in N0-N2b Oropharyngeal Cancer Patients Treated With Definitive Chemoradiation by Gutiontov, S.I, McBride, S.M, Riaz, N, Gelblum, D, Schupak, K.D, Wolden, S.L, Dutta, P.R, Lee, J.E, Lee, N, Tsai, C.J

Get full text

Evaluating the Role of PET/CT Imaging in the Postoperative Setting of Oral Cavity Squamous Cell Cancers Prior to Adjuvant Radiation Therapy by Dutta, P.R, Riaz, N, Morris, L, Patel, S, Ganly, I, Wong, R, Heiko, S, Lee, N

Get full text

Constraining the Brachial Plexus Does Not Compromise Regional Control in Oropharyngeal Carcinoma by Mutter, R.W, Lok, B, Dutta, P.R, Setton, J, Berry, S, Goenka, A, Rao, S.S, Wolden, S, Lee, N

Get full text

The HEART Team Protocol: A Strategic Approach to High-Risk Patient Management in Adult Oncology to Reduce Emergency Room Visits and Hospital Admissions by Seo, Y.J., Bressler, T., Dutta, P.R.

“…Annually, over 1.5 million Americans visit an emergency department (ED) for complications related to cancer treatment. Patients receiving multimodal…”
Get full text

Intensity-modulated Radiation Therapy for the Treatment of Oropharyngeal Carcinoma: The Hospital of the University of Pennsylvania Experience by Dutta, P.R, BarAd, V, Both, S, Dosoretz, A, Lustig, R.A, Weinstein, G, Quon, H

Get full text

Timing and Disclosure of Complementary and Alternative Medical Practices (CAM) in Patients Receiving Radiation Therapy by Dutta, P.R, Yee, S.S, Solin, L.J, Kao, G.D, Vapiwala, N

Get full text

Compliance With National Vaccination Guidelines in Patients Receiving Radiation Therapy by Yee, S.S, Dutta, P.R, Solin, L.J, Vapiwala, N, Kao, G.D

Get full text

Association Between Esophageal Stricture Formation and Dose Volume Histogram (DVH) Parameters in Oropharyngeal Cancer Patients Treated With Intensity Modulated Radiation Therapy (IMRT) by Both, S, Dutta, P.R, Bar Ad, V, Quon, H

Get full text

Serological evidence of Neospora caninum infection in mithun ( Bos frontalis) from India by Rajkhowa, S., Rajkhowa, C., Dutta, P.R., Michui, Paihem, Das, R.

“…Studies conducted on mithuns maintained at National Research Centre on mithun, Indian Council of Agricultural Research (ICAR), Nagaland, India and mithuns…”
Get full text

GliaSite Brachytherapy for Treatment of Recurrent Malignant Gliomas and Metastases: A Retrospective Single-institutional Analysis by Dutta, P.R, Mesina, C.F, Lopinto, J, Judy, K, O'Rourke, D, LeRoux, P, Ingram, M, Lustig, R

Get full text

Prospective Personalized Elective Nodal Dose De-Escalation in Patients with Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer (OPC) Undergoing Definitive Concurrent Chemoradiation (CCRT): Acute Toxicities and Tolerance by Tsai, C.J., Kim, J.K., McBride, S., Gelblum, D., Riaz, N., Dutta, P.R., Parhar, P.K., Schupak, K.D., Higginson, D.S., Mueller, B.A., Lee, N.

Get full text

Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC) by Fury, M.G., Sherman, E.J., Rao, S.S., Wolden, S., Smith-Marrone, S., Mueller, B., Ng, K.K., Dutta, P.R., Gelblum, D.Y., Lee, J.L., Shen, R., Kurz, S., Katabi, N., Haque, S., Lee, N.Y., Pfister, D.G.

“…There is a clinical need to improve the efficacy of standard cetuximab + concurrent intensity-modulated radiation therapy (IMRT) for patients with locally…”
Get full text

Bluetongue infection rate in mithum (Bos frontalis) in the north-eastern upland region of India: EN- -FR- Taux d'infection par la fèvre catarrhale du mouton chez le gayal (Bos frontalis) dans la région des hauts plateaux en Inde nord-orientale -ES- Tasa de onfección por lengua azul del gayal (Bos frontalis) en las tierras altas del noreste de la India by RAJKHOWA, S., RAJKHOWA, C., DUTTA, P.R., MICHUI, P., DAS, R.

Get full text